http://www.biocryst.com
BioCryst Pharmaceuticals, Inc. Company Intro
BioCryst designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP).
Industry
Healthcare
BioCryst Pharmaceuticals, Inc. Headquaters
4505 Emperor Boulevard
Durham,27703
United States
BioCryst Pharmaceuticals, Inc. Share price
23 Oct 2020 01:11 GMT
$3.6400
0.05 (1.39 %)
BioCryst Pharmaceuticals, Inc. Market cap
$678.013 M
WMC RANKING
2020
BioCryst Pharmaceuticals, Inc. # 87
BiotechnologyLatest BioCryst Pharmaceuticals, Inc. News
24 Oct 2020
Influenza Vaccination Market – Insights on Challenges ...
BioCryst Pharmaceuticals, Inc. (U.S.). Novartis AG ... Hualan Biological Engineering Inc (Asia Pacific). Mitsubishi Tanabe Pharma Corporation (Asia Pacific).
25 Oct 2020
Ebola Treatment Market Is Forecasted To Register A CAGR Growth Of XX% Between And 2016 – 2024
BioCryst Pharmaceuticals, Inc. NanoViricides, Inc. NewLink Genetics Corporation; Chimerix, Inc. Sarepta Therapeutics; Mapp Biopharmaceutical, Inc. The ...
25 Oct 2020
T-Cell Lymphoma Market: Qualitative Analysis of the Leading ...
... T-Cell Lymphoma market are Biocryst Pharmaceuticals Inc.,Novartis,Genmab AS,Bristol-Myers Squibb,Spectrum Pharmaceuticals,Johnson & Johnson,Merck ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| BioCryst Pharmaceuticals, Inc. | 0.88 | 1.14 | 0 | 0 | 0 | 0 | 0.87 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.26 | 100 | 18 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.09 | 25 | 0 | 0 | 98.33 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.80 |
| Incyte Corporation | 40.27 | 14.26 | 7.21 | 100 | 0 | 0 | 92.34 |
BioCryst Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| BioCryst Pharmaceuticals, Inc. | $48,835 | $144,189 | $-108,897 | $678.013M | 87 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.228B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $54.719B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.699B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.79B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total BioCryst Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Book a demo
A free one-on-one demo with one of our team and see exactly what the WMC business intelligence platform can do for your organisation.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
